Epidemiology and clinical characteristics of @entity5125 XXXX in a Taiwanese medical center.

@entity1 @entity2176 @entity5 @entity649 @entity114 @entity5125 @entity281 @entity869 @entity221 @entity2259
BACKGROUND/PURPOSE: There have been many reported cases of @entity5125 @entity2259 in Europe and the United States, but only a few from Taiwan. The present study was undertaken to analyze the clinical characteristics of @entity1 with @entity5125 @entity2259 in Taiwan. METHODS: @entity1 with culture-confirmed @entity5125 @entity2259 were identified at Chang Gung Memorial Hospital between January 2001 and December 2008. The clinical features and outcomes of the @entity1 and the antimicrobial susceptibilities of the clinical isolates were analyzed. RESULTS: Forty-three @entity1 , including two newborn babies (4.7%) and 41 adults (95.3%), with at least one episode of Listeria @entity2259 were identified. Forty-two (97.7%) of these @entity1 had underlying diseases. Thirty-three @entity1 (76.7%) had @entity221 , 14 (32.6%) had experienced @entity649 , and 11 (25.6%) had reported changes in consciousness. Twelve @entity1 died within 14 days of @entity281 , corresponding to a case-fatality rate of 27.9%. All the clinical isolates tested were susceptible to @entity869 , @entity114 and @entity2176 . CONCLUSION: Most cases of @entity5125 @entity281 occurred in adults with underlying diseases, especially @entity5 , and only two cases of neonatal @entity5125 @entity2259 were identified over the 8-year period. @entity114 , @entity869 and @entity2176 could be used for the treatment of @entity5125 @entity2259 , with the case-fatality rate lower for @entity1 who received appropriate treatment.
